Detalhe da pesquisa
1.
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results.
Ann Oncol
; 29(1): 133-138, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29045659
2.
Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results.
Ann Oncol
; 29(11): 2270, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29718089
3.
TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy.
Br J Cancer
; 100(8): 1330-5, 2009 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-19367287
4.
Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer.
Eur J Cancer
; 97: 16-24, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29777975